RedHill Biopharma (RDHL) Net Margin Growth (3y) (2015 - 2023)

RedHill Biopharma (RDHL) Net Margin Growth (3y) (2015 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1,620.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -98.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4,358.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,235.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -100.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4,252.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -404.00
10 RedHill Biopharma 640,064.98 640,064.98 - -

Historic Data

Download Data
DateValue
Jun 30, 2023 328,068.00
Mar 31, 2023 -22,003.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.00
Sep 30, 2020 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Jun 30, 2019 0.00
Dec 31, 2018 0.00
Jun 30, 2018 -1.00
Mar 31, 2018 0.00
Dec 31, 2017 -1.00
Sep 30, 2017 0.00
Jun 30, 2017 0.00